The NIH plans to invest $190M during the next 6 years to fund researchers developing tools and technologies to ensure safety and effectiveness in genome editing in humans, focus on non-reproductive somatic cells. NIH Director Dr. Francis S. Collins declare yesterday that “Genome editing technologies such as CRISPR/Cas9 are revolutionizing biomedical research. The focus of the … Read more
If our reporting has informed or inspired you, please consider making a donation. Every contribution, no matter the size, empowers us to continue delivering accurate, engaging, and trustworthy science and medical news. Independent journalism requires time, effort, and resources—your support ensures we can keep uncovering the stories that matter most to you.
Join us in making knowledge accessible and impactful. Thank you for standing with us!